Literature DB >> 13284734

The role of the hexose monophosphate shunt in tumors and lymphatic tissues.

S KIT.   

Abstract

Entities:  

Keywords:  HEXOSEPHOSPHATES/metabolism; LYMPHATIC VESSELS/metabolism; NEOPLASMS/metabolism in

Mesh:

Substances:

Year:  1956        PMID: 13284734

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

1.  The oxidation of various precursors in normal and tumour-bearing mice in vivo.

Authors:  J KABARA; G OKITA
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Metabolism of the normal cardiovascular wall. 2. The pentose phosphate pathway.

Authors:  P BEACONSFIELD
Journal:  Experientia       Date:  1962-06-15

3.  Levels of oxidized and reduced diphosphopyridine nucleotide and triphosphopyridine nucleotide in tumours.

Authors:  G E GLOCK; P MCLEAN
Journal:  Biochem J       Date:  1957-02       Impact factor: 3.857

4.  Tumour glucose-6-phosphate dehydrogenase inhibition by actinomycin.

Authors:  D M Goldenberg; S Witte; W Ernstberger
Journal:  Experientia       Date:  1967-11-15

5.  [Pentose phosphate shunt in the human endometrium].

Authors:  H Hackl
Journal:  Arch Gynakol       Date:  1971-12-31

Review 6.  Exercise and the immune response.

Authors:  D Keast; K Cameron; A R Morton
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

7.  Activities of enzymes of the hexose monophosphate pathway in nervous system tumors induced by ethylnitrosourea.

Authors:  M T Coleman; N Allen
Journal:  Acta Neuropathol       Date:  1978-03-15       Impact factor: 17.088

8.  Stimulation of pentose phosphate pathway dehydrogenase enzyme activities in ethionine-treated mice.

Authors:  H G Sie; W H Fishman
Journal:  Biochem J       Date:  1968-02       Impact factor: 3.857

9.  The metabolism of neoplastic tissues: demonstration of intermediates and reaction sequences of the hexose monophosphate oxidative pathway.

Authors:  L BOSCH; G H VAN VALS; P EMMELOT
Journal:  Br J Cancer       Date:  1956-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.